Serum Separation Gel Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 4.60 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Serum Separation Gel Market Analysis
The Serum Separation Gel Market studied was anticipated to grow with a CAGR of 4.6% during the forecast period. The major factors attributing to the growth of the market are a rise in the number of blood tests and blood banks to examine state and type of blood. Rising prevalence of Bloodstream infections diseases like nosocomial candidemia has increased the demand for the products. For instance, as per the study report published by the National Center for Biotechnology in 2019, nosocomial candidemia is the most common bloodstream infection, associated with significant morbidity and mortality across the globe. Also, a rise in awareness among the public about infectious disease diagnosis is expected to result in a greater number of new examinations propelling the serum separation gel market.
Serum Separation Gel Market Trends
This section covers the major market trends shaping the Serum Separation Gel Market according to our research experts:
Serum Separation Gel Integrated with Tubes are Expected to Hold the Major Market Share in the Serum Separation Gels Market
The serum separation gels integrated with the tube are is expected to dominate the industry over the forecast period. The lucrative growth of the segment can be attributed to a rise in the adoption of these tubes for clinical research purposes in pathological science to control the growing global burden of infectious disease. The huge demand for increased application of these tubes can be due to their enhanced convenience and sample handling. Also, due to their advantages such as higher resistance to irradiation, lower interference on clinical test results, and others are expected to boost the growth of the market.
North America Dominates the Market and Expected to do Same in the Forecast Period.
North America is expected to dominate the global serum separation gels market throughout the forecast period. This dominance is mainly owing to a steep rise in the incidence of hematological disorders and various infectious diseases in the region. Most of the cases were recorded among the elder population demanding the growth of the market in the region. As per the Centers for Disease Control and Prevention (CDC) report published in 2019, bloodstream infections are 4th most common cause of mortality among the people aged 60 or above. Thus, due to the presence of a huge number of baby boomers, the United States registers the highest market revenue. Also, the higher availability of favorable co-pay systems and an increased number of blood banks with advanced infrastructure boost market growth. Furthermore, a rising preference for digital healthcare services among the public to access personal health and fitness in the region contributes to its outstanding share in the growth of the global market.
Serum Separation Gel Industry Overview
The global serum separation gels market is moderately competitive and consists of several major players. Some prominent players in the market are implementing various strategies such as launching new products with the rise in the serology research fundings and collaborations. While others are focusing on mergers & acquisitions to consolidate their market positions across the globe during the forecast period. Some of the companies which are currently dominating the market are Cardinal Health Inc, IntervacTechnology, Becton Dickinson & Company, Greiner Bio-One International GmbH, and Sekisui Diagnostics
Serum Separation Gel Market Leaders
cardinal Health, Inc.
InterVacTechnology OU
Becton Dickinson & Company
Greiner Bio One International GmbH
*Disclaimer: Major Players sorted in no particular order
Serum Separation Gel Market Report - Table of Contents
-
1. INTRODUCTION
-
1.1 Study Deliverables
-
1.2 Study Assumptions
-
1.3 Scope of the Study
-
-
2. RESEARCH METHODOLOGY
-
3. EXECUTIVE SUMMARY
-
4. MARKET DYNAMICS
-
4.1 Market Overview
-
4.2 Market Drivers
-
4.2.1 Growing Global Prevalence of Infections and Rise in Geriatric Population
-
4.2.2 Increased Number of Contract Research Oragnisations in the Biotechnology Industry
-
-
4.3 Market Restraints
-
4.3.1 Highly Expensive Serum Separation Gel Tubes
-
-
4.4 Porter's Five Force Analysis
-
4.4.1 Threat of New Entrants
-
4.4.2 Bargaining Power of Buyers/Consumers
-
4.4.3 Bargaining Power of Suppliers
-
4.4.4 Threat of Substitute Products
-
4.4.5 Intensity of Competitive Rivalry
-
-
-
5. MARKET SEGMENTATION
-
5.1 Product Type
-
5.1.1 Serum Separation Gel Integrated with Tube
-
5.1.2 Serum Separation Gel without Tubes
-
-
5.2 End-Users
-
5.2.1 Hospital
-
5.2.2 Blood Bank
-
5.2.3 Pharmaceutical & Biotechnology Companies
-
5.2.4 Others
-
-
5.3 Geography
-
5.3.1 North America
-
5.3.1.1 United States
-
5.3.1.2 Canada
-
5.3.1.3 Mexico
-
-
5.3.2 Europe
-
5.3.2.1 Germany
-
5.3.2.2 United Kingdom
-
5.3.2.3 France
-
5.3.2.4 Italy
-
5.3.2.5 Spain
-
5.3.2.6 Rest of Europe
-
-
5.3.3 Asia-Pacific
-
5.3.3.1 China
-
5.3.3.2 Japan
-
5.3.3.3 India
-
5.3.3.4 Australia
-
5.3.3.5 South Korea
-
5.3.3.6 Rest of Asia-Pacific
-
-
5.3.4 Middle-East and Africa
-
5.3.4.1 GCC
-
5.3.4.2 South Africa
-
5.3.4.3 Rest of Middle-East and Africa
-
-
5.3.5 South America
-
5.3.5.1 Brazil
-
5.3.5.2 Argentina
-
5.3.5.3 Rest of South America
-
-
-
-
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
-
6.1.1 Cardinal Health, Inc.
-
6.1.2 InterVacTechnology OU
-
6.1.3 Becton Dickinson & Company
-
6.1.4 Greiner Bio One International GmbH
-
6.1.5 Sekisui Diagnostics, LLC
-
6.1.6 FL MEDICAL srl Unipersonale
-
6.1.7 BIOSIGMA S.r.l.
-
6.1.8 BioVision, Inc.
-
6.1.9 Bio-Rad Laboratories Inc.
-
6.1.10 Danaher Corporation
-
- *List Not Exhaustive
-
-
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Serum Separation Gel Industry Segmentation
Serum separation gels are substances used to separate a blood clot and serum with higher stability and reliability to minimize the influence on clinical test results. These are mostly available in the form of serum separation tubes (SSTs) used for collecting blood samples in clinical chemistry assays.
| Product Type | |
| Serum Separation Gel Integrated with Tube | |
| Serum Separation Gel without Tubes |
| End-Users | |
| Hospital | |
| Blood Bank | |
| Pharmaceutical & Biotechnology Companies | |
| Others |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Serum Separation Gel Market Research FAQs
What is the current Serum Separation Gel Market size?
The Serum Separation Gel Market is projected to register a CAGR of 4.60% during the forecast period (2024-2029)
Who are the key players in Serum Separation Gel Market?
cardinal Health, Inc., InterVacTechnology OU, Becton Dickinson & Company and Greiner Bio One International GmbH are the major companies operating in the Serum Separation Gel Market.
Which is the fastest growing region in Serum Separation Gel Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Serum Separation Gel Market?
In 2024, the North America accounts for the largest market share in Serum Separation Gel Market.
What years does this Serum Separation Gel Market cover?
The report covers the Serum Separation Gel Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Serum Separation Gel Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Serum Separation Gel Industry Report
Statistics for the 2024 Serum Separation Gel market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Serum Separation Gel analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
